The document summarizes the UWCCC/WON Molecular Tumor Board (MTB) and Registration Protocol. The MTB is a panel of experts that provides treatment recommendations based on pathology or genomics analysis. Physicians can submit cases for review to receive recommendations for clinical trials, off-label drugs, or standard treatment. The Registration Protocol collects genomic, clinical, and outcome data to evaluate the effectiveness of targeted therapies recommended by the MTB.